Peptide histidine isoleucine-like immunoreactivity release from the rat gastric fundus - PubMed
Peptide histidine isoleucine-like immunoreactivity release from the rat gastric fundus
D Currò et al. Br J Pharmacol. 1994 Oct.
Abstract
1. Longitudinal muscle strips from the rat gastric fundus were subjected to in vitro electrical field stimulation (EFS) under non-adrenergic non-cholinergic (NANC) conditions to study the release of peptide histidine isoleucine-like immunoreactivity (PHI-LI) and the correlation between PHI-LI release and NANC relaxation. 2. Different radioimmunoassay (RIA) systems employing C-terminal- and N-terminal-specific anti-PHI sera were used to determine the relative contributions of PHI and its C-terminally extended forms, peptide histidine glycine (PHI-Gly) and peptide histidine valine [PHV(1-42)], to the PHI-LI released by the rat gastric fundus. 3. In the presence of atropine (1 microM) and guanethidine (5 microM), EFS (120 mA, 1 ms, 0.25-32.0 Hz, trains of 2 min) induced frequency-dependent relaxations of 5-hydroxytryptamine (3 microM) pre-contracted strips. 4. EFS at frequencies of 8-32 Hz evoked significant increases in PHI-LI outflow. The increases in PHI-LI outflow evoked by 16-Hz EFS were abolished by tetrodotoxin (3 microM) and by a calcium-free medium, indicating an active release process from intramural nerves. 5. The EFS-induced release of PHI-LI measured with the N-terminal-specific antiserum was significantly greater than that detected with the C-terminal-specific antisera. 6. Sephadex G-25 gel permeation chromatographic analysis was performed on the PHI-LI release in response to 32-Hz EFS. A C-terminal-specific antiserum revealed one peak co-eluting with the rat PHI standard. When PHI-LI was measured with the N-terminal-specific antiserum, two peaks were found that co-eluted with the rat PHV(1-42) and rat PHI-Gly/PHI standards, respectively. 7. The present data suggest that the extended forms of PHI are the primary components of the PHI-LI released by NANC inhibitory neurones in the rat gastric fundus and support a NANC inhibitory neurotransmitter role for PHI and its extended forms in this tissue.
Similar articles
-
Currò D, Volpe AR, Preziosi P. Currò D, et al. Br J Pharmacol. 1996 Feb;117(4):717-23. doi: 10.1111/j.1476-5381.1996.tb15249.x. Br J Pharmacol. 1996. PMID: 8646419 Free PMC article.
-
Currò D, De Marco T, Preziosi P. Currò D, et al. Naunyn Schmiedebergs Arch Pharmacol. 2002 Dec;366(6):578-86. doi: 10.1007/s00210-002-0633-z. Epub 2002 Sep 27. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 12444500
-
Release of vasoactive intestinal polypeptide from the rat gastric fundus.
D'Amato M, Currò D, Montuschi P, Ciabattoni G, Ragazzoni E, Lefebvre RA. D'Amato M, et al. Br J Pharmacol. 1992 Mar;105(3):691-5. doi: 10.1111/j.1476-5381.1992.tb09040.x. Br J Pharmacol. 1992. PMID: 1352721 Free PMC article.
-
D'Amato M, Currò D, Ciabattoni G, Lefebvre RA. D'Amato M, et al. Arch Int Pharmacodyn Ther. 1990 Jan-Feb;303:216-31. Arch Int Pharmacodyn Ther. 1990. PMID: 1973609
-
Curro D, Preziosi P. Curro D, et al. Br J Pharmacol. 1997 Jul;121(6):1105-12. doi: 10.1038/sj.bjp.0701245. Br J Pharmacol. 1997. PMID: 9249245 Free PMC article.
Cited by
-
Currò D, De Marco T, Preziosi P. Currò D, et al. Br J Pharmacol. 2004 Nov;143(6):785-93. doi: 10.1038/sj.bjp.0705993. Epub 2004 Oct 25. Br J Pharmacol. 2004. PMID: 15504756 Free PMC article.
-
Currò D, Volpe AR, Preziosi P. Currò D, et al. Br J Pharmacol. 1996 Feb;117(4):717-23. doi: 10.1111/j.1476-5381.1996.tb15249.x. Br J Pharmacol. 1996. PMID: 8646419 Free PMC article.
-
Roles of PACAP and PHI as inhibitory neurotransmitters in the circular muscle of mouse antrum.
Toyoshima M, Takeuchi T, Goto H, Mukai K, Shintani N, Hashimoto H, Baba A, Hata F. Toyoshima M, et al. Pflugers Arch. 2006 Jan;451(4):559-68. doi: 10.1007/s00424-005-1491-6. Epub 2005 Nov 15. Pflugers Arch. 2006. PMID: 16292577
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources